Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 504

1.

TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.

Terry J, Saito T, Subramanian S, Ruttan C, Antonescu CR, Goldblum JR, Downs-Kelly E, Corless CL, Rubin BP, van de Rijn M, Ladanyi M, Nielsen TO.

Am J Surg Pathol. 2007 Feb;31(2):240-6.

PMID:
17255769
2.

Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.

Jagdis A, Rubin BP, Tubbs RR, Pacheco M, Nielsen TO.

Am J Surg Pathol. 2009 Dec;33(12):1743-51. doi: 10.1097/PAS.0b013e3181b7ed36.

PMID:
19809272
3.

TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases.

Knösel T, Heretsch S, Altendorf-Hofmann A, Richter P, Katenkamp K, Katenkamp D, Berndt A, Petersen I.

Eur J Cancer. 2010 Apr;46(6):1170-6. doi: 10.1016/j.ejca.2010.01.032.

PMID:
20189377
4.

TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms.

Kosemehmetoglu K, Vrana JA, Folpe AL.

Mod Pathol. 2009 Jul;22(7):872-8. doi: 10.1038/modpathol.2009.47.

5.

Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma.

Amary MF, Berisha F, Bernardi Fdel C, Herbert A, James M, Reis-Filho JS, Fisher C, Nicholson AG, Tirabosco R, Diss TC, Flanagan AM.

Mod Pathol. 2007 Apr;20(4):482-96.

6.

Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma.

van de Rijn M, Barr FG, Collins MH, Xiong QB, Fisher C.

Am J Clin Pathol. 1999 Jul;112(1):43-9.

PMID:
10396284
7.

Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.

Antonescu CR, Kawai A, Leung DH, Lonardo F, Woodruff JM, Healey JH, Ladanyi M.

Diagn Mol Pathol. 2000 Mar;9(1):1-8.

PMID:
10718206
8.

Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.

Izumi T, Oda Y, Hasegawa T, Nakanishi Y, Kawai A, Sonobe H, Takahira T, Kobayashi C, Yamamoto H, Tamiya S, Hirohashi S, Iwamoto Y, Tsuneyoshi M.

Am J Surg Pathol. 2007 Jan;31(1):85-94.

PMID:
17197923
9.

Immunostaining for SYT protein discriminates synovial sarcoma from other soft tissue tumors: analysis of 146 cases.

He R, Patel RM, Alkan S, Hammadeh R, Weiss SW, Goldblum JR, Venkataraman G, Baila H.

Mod Pathol. 2007 May;20(5):522-8.

10.
11.

Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t(X;18)(SYT-SSX)-positive cases.

Pelmus M, Guillou L, Hostein I, Sierankowski G, Lussan C, Coindre JM.

Am J Surg Pathol. 2002 Nov;26(11):1434-40.

PMID:
12409719
12.

Diagnostic utility of dual-color break-apart chromogenic in situ hybridization for the detection of rearranged SS18 in formalin-fixed, paraffin-embedded synovial sarcoma.

Motoi T, Kumagai A, Tsuji K, Imamura T, Fukusato T.

Hum Pathol. 2010 Oct;41(10):1397-404. doi: 10.1016/j.humpath.2010.02.009.

PMID:
20594581
13.

Diagnosis of synovial sarcoma with the reverse transcriptase-polymerase chain reaction: analyses of 84 soft tissue and bone tumors.

Hiraga H, Nojima T, Abe S, Sawa H, Yamashiro K, Yamawaki S, Kaneda K, Nagashima K.

Diagn Mol Pathol. 1998 Apr;7(2):102-10.

PMID:
9785009
14.

Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.

Thomas DG, Giordano TJ, Sanders D, Biermann S, Sondak VK, Trent JC, Yu D, Pollock RE, Baker L.

Cancer. 2005 Feb 15;103(4):830-8.

15.

Molecular and immunohistochemical analysis of HER2/neu oncogene in synovial sarcoma.

Nuciforo PG, Pellegrini C, Fasani R, Maggioni M, Coggi G, Parafioriti A, Bosari S.

Hum Pathol. 2003 Jul;34(7):639-45.

PMID:
12874758
16.

Reappraisal of TLE-1 immunohistochemical staining and molecular detection of SS18-SSX fusion transcripts for synovial sarcoma.

Chuang HC, Hsu SC, Huang CG, Hsueh S, Ng KF, Chen TC.

Pathol Int. 2013 Dec;63(12):573-80. doi: 10.1111/pin.12113.

PMID:
24422953
17.

Expression profiling in soft tissue sarcomas with emphasis on synovial sarcoma, gastrointestinal stromal tumor, and leiomyosarcoma.

West RB.

Adv Anat Pathol. 2010 Sep;17(5):366-73. doi: 10.1097/PAP.0b013e3181ec7428. Review.

PMID:
20733355
18.

Tissue microarray profiling of primary and xenotransplanted synovial sarcomas demonstrates the immunophenotypic similarities existing between SYT-SSX fusion gene confirmed, biphasic, and monophasic fibrous variants.

Subramaniam MM, Navarro S, Pellin A, López-Guerrero JA, Carda C, Heredia Alvaro JA, Gozalbo Sabater PL, Llombart-Bosch A.

Virchows Arch. 2006 Oct;449(4):435-47.

PMID:
16957934
19.

Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics.

Foo WC, Cruise MW, Wick MR, Hornick JL.

Am J Clin Pathol. 2011 Jun;135(6):839-44. doi: 10.1309/AJCP45SSNAOPXYXU.

PMID:
21571956
20.

HMGA proteins in malignant peripheral nerve sheath tumor and synovial sarcoma: preferential expression of HMGA2 in malignant peripheral nerve sheath tumor.

Hui P, Li N, Johnson C, De Wever I, Sciot R, Manfioletti G, Tallini G.

Mod Pathol. 2005 Nov;18(11):1519-26.

Items per page

Supplemental Content

Support Center